Erysipelas and Cellulitis: A Retrospective Study of 122 Cases

{ "0" : "Departamento de Dermatología, Facultad de Medicina, Complejo Hospitalario Universitario, Santiago de Compostela, A Coruña, Spain" , "2" : "epidemiology" , "3" : "erysipelas" , "4" : "cellulitis" , "5" : "infection" , "6" : "epidemiología" , "7" : "erisipela" , "8" : "celulitis" , "9" : "infección"}
Actas Dermo-Sifiliográficas (English Edition) 11/2009; DOI: 10.1016/S1578-2190(09)70560-8

ABSTRACT BackgroundErysipelas and cellulitis are relatively common cutaneous infections that can sometimes be the cause of a prolonged hospital admission. The objective of this study was to determine the most relevant epidemiologic factors and their influence on the length of hospital stay, comparing our results with those of previous studies.Material and methodsWe performed a retrospective, observational, cross-sectional study of 122 patients admitted over a 5-year period to the dermatology department of our hospital with a diagnosis of erysipelas or cell.ResultsPatients with a diagnosis of erysipelas or cellulitis represented 8.6% of all admissions during the study period. The mean age was 58.93 years and the female to male ratio was 1.06:1. The most common site of involvement was on the legs (76.22%). Overweight or obesity was present in 42.6% of patients and tinea pedis was detected in 33.6% of cases. A skin abscess developed in 7.4% of cases. The mean length of admission was 10.20 days; length of stay increased with age and with the erythrocyte sedimentation rate (ESR) on admission (P<.01 for both differences).ConclusionsWe confirm general epidemiologic factors such as sex and age distributions, predominant site, past history, and length of hospital stay. In view of their predictive value for the length of hospital stay, we propose that age and the ESR on admission should be considered to be indirect indicators of disease severity.ResumenIntroducción y objetivosELas erisipelas/celulitis son infecciones cutáneas relativamente frecuentes que en ocasiones requieren una estancia hospitalaria prolongada de los pacientes. Nos proponemos describir los hallazgos epidemiológicos más relevantes y su influencia en el incremento de la estancia hospitalaria, comparando nuestros resultados con trabajos previos.Material y métodosEstudio observacional, transversal y retrospectivo a partir de un total de 122 pacientes ingresados con el diagnóstico de erisipela/celulitis en el Servicio de Dermatología de nuestro hospital durante un periodo de 5 años.ResultadosLas erisipelas/celulitis constituyeron el 8,6% de todos los casos ingresados durante el periodo estudiado. La edad media fue de 58,93 años, con una relación mujer:hombre de 1,06. La localización más frecuente fue las extremidades inferiores con el 76,22% de los casos. El 42,6% presentó obesidad o sobrepeso; el 33,6% mostró tiña del pie y el 7,4% desarrolló un absceso cutáneo. La estancia hospitalaria media fue de 10,20 días, aumentando conforme se incrementaba la edad del paciente (p < 0,01) o el valor de la velocidad de sedimentación globular (VSG) al ingreso (p < 0,01).ConclusionesSe confirman los preceptos epidemiológicos generales acerca de distribución por sexos y edades, localizaciones predilectas, antecedentes y estancia hospitalaria. Se propone considerar el valor de la VSG al ingreso y la edad como un indicador indirecto de la gravedad del cuadro, dado su valor predictivo de la estancia hospitalaria.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In contemporary medicine, the erythrocyte sedimentation rate (ESR) is used to assess severity in patients with such diseases as erysipelas, psoriasis, eosinophilic fasciitis, dermatomyositis, and Behçet's disease. We remember the scientific achievements of a Polish physician, the discoverer of the erythrocyte sedimentation rate (ESR), Edmund Faustyn Biernacki (1866-1911), on the 100th anniversary of his death. The practical application of ESR in clinical diagnostics in 1897 by Biernacki was little known for many years, because it was often neglected owing to the work of Robert Fåhraeusand Alf Westergren from 1921. In addition, it is also frequently omitted that before Westergren's and Fåhraeus's reports were published, ESR was also noticed by Ludwig Hirschfeld in 1917.
    Clinics in dermatology 11/2011; 29(6):697-703. · 3.11 Impact Factor